| Product Code: ETC9956799 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Tumor Profiling Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Tumor Profiling Market - Industry Life Cycle |
3.4 United Kingdom (UK) Tumor Profiling Market - Porter's Five Forces |
3.5 United Kingdom (UK) Tumor Profiling Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.6 United Kingdom (UK) Tumor Profiling Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United Kingdom (UK) Tumor Profiling Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Tumor Profiling Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the UK |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in tumor profiling techniques |
4.3 Market Restraints |
4.3.1 High cost associated with tumor profiling tests |
4.3.2 Limited reimbursement policies for tumor profiling services |
4.3.3 Stringent regulatory requirements for approval of tumor profiling technologies |
5 United Kingdom (UK) Tumor Profiling Market Trends |
6 United Kingdom (UK) Tumor Profiling Market, By Types |
6.1 United Kingdom (UK) Tumor Profiling Market, By Technique |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Technique, 2021- 2031F |
6.1.3 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Genomics, 2021- 2031F |
6.1.4 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Proteomics, 2021- 2031F |
6.1.5 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Metabolomics, 2021- 2031F |
6.1.6 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Epigenetics, 2021- 2031F |
6.2 United Kingdom (UK) Tumor Profiling Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Sequencing Techniques, 2021- 2031F |
6.2.3 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.2.4 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.2.5 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By qPCR, 2021- 2031F |
6.2.6 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Microarray, 2021- 2031F |
6.3 United Kingdom (UK) Tumor Profiling Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Personalized Medicine, 2021- 2031F |
6.3.3 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Oncological Diagnostics, 2021- 2031F |
6.3.4 United Kingdom (UK) Tumor Profiling Market Revenues & Volume, By Research, 2021- 2031F |
7 United Kingdom (UK) Tumor Profiling Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Tumor Profiling Market Export to Major Countries |
7.2 United Kingdom (UK) Tumor Profiling Market Imports from Major Countries |
8 United Kingdom (UK) Tumor Profiling Market Key Performance Indicators |
8.1 Adoption rate of tumor profiling services by healthcare providers |
8.2 Number of partnerships and collaborations in the tumor profiling market |
8.3 Rate of introduction of new tumor profiling technologies and tests |
8.4 Patient outcomes and survival rates post tumor profiling analysis |
9 United Kingdom (UK) Tumor Profiling Market - Opportunity Assessment |
9.1 United Kingdom (UK) Tumor Profiling Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.2 United Kingdom (UK) Tumor Profiling Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United Kingdom (UK) Tumor Profiling Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Tumor Profiling Market - Competitive Landscape |
10.1 United Kingdom (UK) Tumor Profiling Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Tumor Profiling Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here